Clinical trial Recruiting at 1 site Interventional Ages 18 to 50

Extracorporeal shock wave therapy after flexor tendon repair in the hand

Official title: The Effect of Extracorporeal Shock Wave Therapy on Range of Motion, Pain, Dexterity, and Function After Hand Flexor Tendon Injury.

Run by Kirsehir Ahi Evran Universitesi · NCT07320807 · Data updated 2026-11-12

This will test whether adding extracorporeal shock wave therapy to standard rehabilitation helps people 8–12 weeks after flexor tendon repair in the hand regain motion, reduce pain, and improve grip and dexterity.

More Tendon Injury - Hand trials

Quick facts

Study typeInterventional
Ages18 Years to 50 Years
SexAll
Enrollment56 (estimated)
SponsorKirsehir Ahi Evran Universitesi
Academic / other
Locations1 site (Ankara)
StatusRecruiting
StartedJanuary 15, 2026
Main results expectedApril 30, 2026
Study endsMay 30, 2026
Registry record updatedMay 11, 2026
Trial IDNCT07320807 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people 8–12 weeks after surgical repair of hand flexor tendons (zones II–IV) who can attend clinic visits and have no exclusion conditions.

Probably not a fit

Patients with active infection or open wounds, pregnant individuals, those with recent finger or wrist fractures, inflammatory rheumatic disease, or cancer, or those outside the 8–12 week post‑operative window are unlikely to be eligible or to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional protocol adds extracorporeal shock wave therapy (ESWT) to a standard rehabilitation program and compares outcomes with rehabilitation alone in patients 8–12 weeks after surgical repair of flexor tendons in zones II–IV. The intervention group receives ESWT sessions in addition to the same rehabilitation program given to the control group, and outcomes measured include range of motion, pain, grip strength, and hand dexterity. Common exclusion criteria include active infection, open wounds, pregnancy, recent finger or wrist fractures, inflammatory rheumatic disease, and malignancy. Treatments and follow-up visits are conducted at Ankara Bilkent City Hospital.

Why it matters

Potential benefit: If successful, adding ESWT could speed functional recovery, reduce pain, and lower adhesion-related stiffness after flexor tendon repair.

How similar studies have gone: Animal studies and small human reports, including positive findings in Dupuytren’s disease and some tendon cases, have suggested benefits of ESWT, but high‑quality randomized evidence specifically after flexor tendon repair is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* • . Volunteering

  * . Being 8-12 weeks post-operatively after flexor tendon repair
  * . Having undergone flexor tendon zone II-IV surgical repair

Exclusion Criteria:

* . Infection

  * • . Open wound

    * . Pregnancy
    * . History of finger or wrist fracture
    * . Inflammatory rheumatic disease
    * . Malignant tumor mass

Where it's running

  • Ankara Bilkent City Hospital
    Ankara, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.